Clinical Trial Update: FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF) [NA]

View source ↗

Summary

Clinical trial update for FIRM Ablation versus Pulmonary Vein Isolation in paroxysmal atrial fibrillation; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• FIRM Ablation
• Pulmonary Vein Isolation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: TERMINATED | Results posted: 2019-05-21